CXC chemokine receptor 1 predicts postoperative prognosis and chemotherapeutic benefits for TNM II and III resectable gastric cancer patients
Open Access
- 21 October 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (12) , 20328-20339
Abstract
CXC chemokine receptor 1 predicts postoperative prognosis and chemotherapeutic benefits for TNM II and III resectable gastric cancer patientsKeywords
This publication has 37 references indexed in Scilit:
- Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modellingOncotarget, 2015
- Effects of 5-fluorouracil and gemcitabine on a breast cancer cell line (MCF-7) via the JAK/STAT pathwayActa Histochemica, 2012
- Structure of the chemokine receptor CXCR1 in phospholipid bilayersNature, 2012
- Breast cancer stem cells, cytokine networks, and the tumor microenvironmentJournal of Clinical Investigation, 2011
- p38γ MAPK Cooperates with c-Jun in trans-Activating Matrix Metalloproteinase 9Journal of Biological Chemistry, 2010
- STATs in cancer inflammation and immunity: a leading role for STAT3Nature Reviews Cancer, 2009
- High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular CarcinomaJournal of Clinical Oncology, 2008
- HIF-1 and NF-κB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cellsOncogene, 2007
- Adjuvant Therapy in Gastric CancerJournal of Clinical Oncology, 2005
- Structure and Functional Expression of a Human Interleukin-8 ReceptorScience, 1991